Fetal programming of dietary fructose and saturated fat on hepatic quercetin glucuronidation in rats

Nutrition

Volumn 28, Issue 11-12, 2012, Pages 1165-1171

  Serra, Aida ^a,b   Bryant, Nyssa ^a   Motilva, Maria José ^b   Blumberg, Jeffrey B ^a   Chen, C Y Oliver ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Fetal programming; Fructose; Quercetin; Rat; Saturated fats; UDP glucuronosyltransferase

Indexed keywords

4' O QUERCETIN GLUCURONIDE; 7 O QUERCETIN GLUCURONIDE; CHOLESTEROL; COCONUT OIL; CORN OIL; FRUCTOSE; GLUCOSE; GLUCURONOSYLTRANSFERASE; QUERCETIN; QUERCETIN DERIVATIVE; SATURATED FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCURONIDATION; IN VITRO STUDY; LACTATION; LIVER MICROSOME; MALE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; DIET, HIGH-FAT; DOWN-REGULATION; FEMALE; FETAL DEVELOPMENT; FRUCTOSE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; LACTATION; LIVER; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICROSOMES, LIVER; PLANT OILS; PREGNANCY; QUERCETIN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

RATTUS; ZEA MAYS;

EID: 84867228541     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.04.004     Document Type: Article

References (33)

1. Cherniack E.P. Polyphenols: planting the seeds of treatment for the metabolic syndrome. Nutrition 2011, 27:617-623.
2. Nishiumi S., Miyamoto S., Kawabata K., Ohnishi K., Mukai R., Murakami A., et al. Dietary flavonoids as cancer-preventive and therapeutic biofactors. Front Biosci 2011, 3:1332-1362.
3. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
4. Mizuma T. Kinetic impact of presystemic intestinal metabolism on drug absorption: experiment and data analysis for the prediction of in vivo absorption from in vitro data. Drug Metab Pharmacokinet 2002, 17:496-506.
5. Bolling B.W., Court M.H., Blumberg J.B., Chen C.Y. The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes. J Nutr Biochem 2010, 21:498-503.
6. Bolling B.W., Court M.H., Blumberg J.B., Chen C.Y. Microsomal quercetin glucuronidation in rat small intestine depends on age and segment. Drug Metab Dispos 2011, 39:1406-1414.
7. Saracino M.R., Lampe J.W. Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention. Nutr Cancer 2007, 59:121-141.
8. Harris R.Z., Jang G.R., Tsunoda S. Dietary effects on drug metabolism and transport. Clin Pharmacokinet 2003, 42:1071-1088.
9. Cheng P.Y., Morgan E.T. Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab 2001, 2:165-183.
10. Osabe M., Sugatani J., Fukuyama T., Ikushiro S., Ikari A., Miwa M. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet. Drug Metab Dispos 2008, 36:294-302.
11. Chmurzynska A. Fetal programming: link between early nutrition, DNA methylation, and complex diseases. Nutr Rev 2010, 68:87-98.
12. Guillemette C., Lévesque E., Harvey M., Bellemare J., Menard V. UGT genomic diversity: beyond gene duplication. Drug Metab Rev 2010, 42:24-44.
13. Ismail-Beigi F., Catalano P.M., Hanson R.W. Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult. Am J Physiol Endocrinol Metab 2006, 291:E439-E440.
14. Tappy L., Lê K.A., Tran C., Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition 2010, 26:1044-1049.
15. Strassburg C.P., Strassburg A., Kneip S., Barut A., Tukey R.H., Rodeck B., Manns M.P. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 2002, 50:259-265.
16. Chen C.Y., Crott J., Liu Z., Smith D.E. Fructose and saturated fats predispose hyperinsulinemia in lean male rat offspring. Eur J Nutr 2010, 49:337-343.
17. Court M.H. Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 2010, 42:209-224.
18. Navarro S.L., Saracino M.R., Makar K.W., Thomas S.S., Li L., Zheng Y., et al. Determinants of aspirin metabolism in healthy men and women: effects of dietary inducers of UDP-glucuronosyltransferases. J Nutrigenet Nutrigenomics 2011, 4:110-118.
19. Iwuchukwu O.F., Tallarida R.J., Nagar S. Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells. Life Sci 2011, 88:1047-1054.
20. Graf B.A., Ameho C., Dolnikowski G.G., Milbury P.E., Chen C.Y., Blumberg J.B. Rat gastrointestinal tissues metabolize quercetin. J Nutr 2006, 136:39-44.
21. Boersma M., van der Woude H., Bogaards J., Boeren S., Vervoort J., Cnubben N., et al. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol 2002, 15:662-670.
22. Lampe J.W. Diet, genetic polymorphisms, detoxification, and health risks. Altern Ther Health Med 2007, 13:S108-S111.
23. Wu B., Kulkarni K., Basu S., Zhang S., Hu M. First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci 2011, 100:3655-3681.
24. Liu W., Tang L., Ye L., Cai Z., Xia B., Zhang J., et al. Species and gender differences affect the metabolism of emodin via glucuronidation. AAPS J 2010, 12:424-436.
25. Gallagher C.J., Balliet R.M., Sun D., Chen G., Lazarus P. Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity. Drug Metab Dispos 2010, 38:2204-2209.
26. Shelby M.K., Cherrington N.J., Vansell N.R., Klaassen C.D. Tissue mRNA expression of the rat UDPglucuronosyltransferase gene family. Drug Metab Dispos 2003, 31:326-333.
27. Mazur C.S., Kenneke J.F., Hess-Wilson J.K., Lipscomb J.C. Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements. Drug Metab Dispos 2010, 38:2232-2238.
28. Dai G., He L., Chou N., Wan Y.J. Acetaminophen metabolism does not contribute to gender difference in its hepatotoxicity in mouse. Toxicol Sci 2006, 92:33-41.
29. Wu B., Xu B., Hu M. Regioselective glucuronidation of flavonols by six human UGT1A isoforms. Pharm Res 2011, 28:1905-1918.
30. Bustamante N., Cantarino M.H., Arahuetes R.M., Cubero F.J., Ortiz A. Evolution of the activity of UGT1A1 throughout the development and adult life in a rat. Life Sci 2006, 78:1688-1695.
31. Smith S.A., Nagalla S.R., Andrews D.P., Olsen G.D. Morphine regulation of a novel uridine diphosphate glucuronosyl-transferase in guinea pig pups following in utero exposure. Mol Genet Metab 1999, 68:68-77.
32. Singh M.S., Michael M. Role of xenobiotic metabolic enzymes in cancer epidemiology. Methods Mol Biol 2009, 472:243-264.
33. Stevenson D., Cooney J., Jensen D., Wibisono R., Adaim A., Skinner M., Zhang J. Comparison of enzymically glucuronidated flavonoids with flavonoid aglycones in an in vitro cellular model of oxidative stress protection. In Vitro Cell Dev Biol Anim 2008, 44:73-80.